Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Alcohol Clin Exp Res. 2012 Aug 30;37(2):223–233. doi: 10.1111/j.1530-0277.2012.01922.x

Figure 2. Effects of the GlyT-1 inhibitor ALX-5407 on EtOH-induced ataxia and LORR duration.

Figure 2

Treatment with ALX-5407 did not alter EtOH-induced rotarod ataxia in B6 (A) or S1 (B) mice (n=7–11/dose/strain). The highest dose of ALX-5407 potentiated (3.5 g/kg) EtOH-induced LORR duration in B6 (C) and S1 (D) mice (n=8–14/dose/strain). Data are means ±SEM. *p<.05 vs. 0 mg/kg